Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Moodys
Cipla
Chubb
Julphar
Johnson and Johnson
US Army
Argus Health
Chinese Patent Office

Generated: October 21, 2018

DrugPatentWatch Database Preview

SILDENAFIL CITRATE Drug Profile

« Back to Dashboard

When do Sildenafil Citrate patents expire, and what generic alternatives are available?

Sildenafil Citrate is a drug marketed by Aurobindo Pharma Ltd, Actavis Grp Ptc, Ajanta Pharma Ltd, Amneal Pharms, Amneal Pharms Ny, Apotex Corp, Dr Reddys Labs Ltd, Hetero Labs Ltd V, Macleods Pharms Ltd, Mylan Pharms Inc, Rubicon Res Pvt Ltd, Teva, Teva Pharms, Torrent Pharms Ltd, and Watson Labs Inc. and is included in twenty NDAs.

The generic ingredient in SILDENAFIL CITRATE is sildenafil citrate. There are twenty drug master file entries for this compound. Forty suppliers are listed for this compound. There are eleven tentative approvals for this compound. Additional details are available on the sildenafil citrate profile page.

Drug patent expirations by year for SILDENAFIL CITRATE
Pharmacology for SILDENAFIL CITRATE
Medical Subject Heading (MeSH) Categories for SILDENAFIL CITRATE
Synonyms for SILDENAFIL CITRATE
1-((3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methyl-,2-hydroxy-1,2,3-propanetricarboxylate
1-((3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate
1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate (1:1)
1-[[3-(4,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate
1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate salt
1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1-h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate
1-{[3-(6,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl}-4-methylpiperazone citrate
139755-83-2 (Parent)
171599-83-0
5-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1,4-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one 2-hydroxypropane-1,2,3-tricarboxylate
5-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one 2-hydroxypropane-1,2,3-tricarboxylate
5-[2-Ethoxy-5-(4-methyl-1-piperazinylsulfonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one citrate
5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonyl-phenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one; 2-oxidanylpropane-1,2,3-tricarboxylic acid
5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one; 2-hydroxypropane-1,2,3-tricarboxylic acid
5-[2-Ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-4H-pyrazolo[5,4-e]pyrimidin-7-one citrate salt
5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one;2-hydroxypropane-1,2,3-tricarboxylic acid
5-[2-Ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)phenyl]-1,3-d]pyrimidin-7-one-citrate
5-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one; 2-hydroxypropane-1,2,3-tricarboxylic acid
5-[2-Ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one 2-hydroxy-1,2,3-propanetricarboxylate
5-[2-Ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one Citrate
5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one 2-hydroxypropane-1,2,3-tricarboxylate
A807582
A811336
AB0089286
AB1009362
AB2000102
AC-1310
AC1L1XX1
Actra-Rx
AKOS015856298
AKOS015951281
AN-15068
Apodefil
BC666107
BCP0726000239
BW9B0ZE037
C28H38N6O11S
C55S832
CAS-171599-83-0
Caverta
CCG-213260
CHEBI:58987
CHEMBL1737
citric acid; 5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonyl-phenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one
citro; sildenafil
CS-1576
D02229
DEIYFTQMQPDXOT-UHFFFAOYSA-N
DSSTox_CID_26076
DSSTox_GSID_46076
DSSTox_RID_81321
DTXSID4046076
Duromist
Edegra
F0001-2406
FT-0082439
FT-0601540
GHL-901
HE072803
HIP-0908
HMS3260C20
HMS3654B08
HY-15025A
I06-1874
IUK-92,480
J-010743
Jsp003501
KS-1112
LS-111685
MFCD09026931
MolPort-003-850-246
MolPort-006-069-375
MolPort-006-823-012
NCGC00095099-05
NCGC00159496-02
NCGC00260784-01
NSC-744009
NSC-758669
NSC744009
NSC758669
NVD-401
Patrex
Penegra
Pharmakon1600-01504099
Piperazine, 1-((3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
Revatio
Revatio (TN)
S0986
s1431
SC-44588
SCHEMBL33982
Sildenafil (citrate)
Sildenafil citrate (JAN/USAN)
Sildenafil citrate [USAN]
Sildenafil citrate salt
Sildenafil citrate salt, >=98% (HPLC)
Sildenafil citrate salt, European Pharmacopoeia (EP) Reference Standard
Sildenafil citrate, European Pharmacopoeia (EP) Reference Standard
Sildenafil Citrate, pharmaceutical secondary standard; traceable to USP, PhEur
Sildenafil citrate, United States Pharmacopeia (USP) Reference Standard
Sildenafil, Citrate
sildenafilcitrate
Tonafil
Tox21_111717
Tox21_111717_1
Tox21_500099
UK 92480
UK 92480-10
UK-92,480
UK-92480-10
UK-9248010
UNII-BW9B0ZE037
VA11751
VIAGRA
Viagra (TN)
Viagra, Sildenafil citrate
Viagra;Revatio
Wan Ai Ke
X-Excite

US Patents and Regulatory Information for SILDENAFIL CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Inc SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 202503-001 Nov 6, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Torrent Pharms Ltd SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 091479-001 Nov 6, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Torrent Pharms Ltd SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 091448-001 Jun 11, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd SILDENAFIL CITRATE sildenafil citrate SOLUTION;INTRAVENOUS 203988-001 Apr 1, 2015 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Macleods Pharms Ltd SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 203814-001 Dec 17, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Moodys
Cipla
Chubb
Julphar
Johnson and Johnson
US Army
Argus Health
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.